Pharma's expensive gaming of the drug patent system is successfully countered by the Medicines Patent Pool, which increases global access and rewards innovation
- Written by Lucy Xiaolu Wang, Assistant Professor of Resource Economics, UMass Amherst
Drug patents don't necessarily spur companies to innovate so much as restrict access to their IP.Andrii Zastrozhnov/iStock via Getty Images PlusBiomedical innovation reached a new era during the COVID-19 pandemic as drug development went into overdrive. But the ways that brand companies license their patented drugs grant them market monopoly,...
